2023 annual financial data
UroGen Pharma 2023 Operating margin
Direct answer
Operating margin was -79.23%.
Operating income was -65,536,000 USD and net income was -102,244,000 USD.
Operating cash flow was -76,376,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 82,713,000 USD
- Operating income
- -65,536,000 USD
- Net income
- -102,244,000 USD
- Operating cash flow
- -76,376,000 USD